Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ACRV)

Q: What does CUSIP 004890109 represent in this 13F holders report?

CUSIP 004890109 is the security identifier for ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") used to aggregate holder disclosures.

Q: How many institutions held ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") in Q1 2026?

43 institutional investors reported ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 004890109

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock, par value $0.001 per share (the "Shares")
Total 13F shares: 16,236,105
Total 13F value: $22,567,622
Share change: -2,509,790
SEC-reported price per share: $1.39
Number of holders: 43
Value change: -$6,159,853
Number of buys: 18
Number of sells: 24
Shares outstanding: 42,655,924

Security key

004890109

Report period

Q1 2026

Institutions

Top holders

ACRV full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Previous quarter: Q4 2025 Acrivon Therapeutics, Inc. SEC filings Acrivon Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 004890109

Newer quarter: Q2 2026 Previous quarter: Q4 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Sands Capital Life Scienc...

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

31 Dec 2025

13D/G 3/4/5 13F Lead comparable stake: 6.8% 13D/G row: Sands Capital Life Sciences Pulse Fund II, L.P. Showing 1-6 of 15 holder rows.

Quick read

Sands Capital Life Sciences Pulse Fund II, L.P. leads the comparable SEC ownership view at 6.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Sands Capital Life Sciences Pulse Fund II, L.P.'s linked filing trail.

Comparable ownership Top 5

Sands Capital Life Sciences Pulse... 6.8%

PERCEPTIVE ADVISORS LLC 7.3%

RA CAPITAL MANAGEMENT, L.P. 20%

Sands Capital Alternatives, LLC 5%

CITADEL ADVISORS LLC 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Sands Capital Life Sciences Pulse Fund II, L.P.	13D/G 13D/G	6.8%	$2,525,900 2,122,605 shares	$0	30 Jun 2025
PERCEPTIVE ADVISORS LLC	3/4/5 10%+ Owner 3/4/5	7.3%	$4,159,546 3,104,139 shares	—	30 Apr 2025
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	20%	$20,100,624 8,340,508 shares	—	31 Dec 2025
Sands Capital Alternatives, LLC	13F Company 13F	5%	$5,115,478 2,122,605 shares	—	31 Dec 2025
CITADEL ADVISORS LLC	13F Company 13F	3.8%	$3,956,941 1,641,884 shares	—	31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	2.1%	$2,140,393 888,130 shares	—	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

16,236,105

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

-5

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend